To the Editor: Patients with end-stage kidney disease (ESKD) are at increased risk for cardiovascular disease (CVD) compared to the general population, because of a number of factors including endothelial dysfunction. 1 Endothelial cells (ECs) arise from progenitors that reside in both the bone marrow and vascular niches, including that of the kidney, 2 and are classified according to specific morphological and functional differences. 3 Endothelial progenitor cells (EPCs) can form "blood-like" islands, which can be measured in a colony-forming unit (CFU) assay 4 in vitro, and late outgrowth ECs (OECs) can home to sites of ischemic injury and contribute to neovascularization. 5, 6 EPCs identified in peripheral blood can be used as indicators of risk of CVD in dialysis patients 7, 8 and play a role in vascular repair by releasing pro-angiogenic growth factors 9 ; yet the effect of clinical parameters on OEC appearance in culture has been lacking. OECs have angiogenic properties and as such have been investigated as a source for cell therapy 10 ; however, their success has been limited because of their early senescence in culture. In this study, we investigate the effect of patient clinical parameters on OEC appearance as a means of furthering the understanding of OECs as a source of cell therapy for vascular injury.
PATIENTS, MATERIALS, AND METHODS
ESKD patients, treated with hemodialysis were recruited (n ¼ 20) from Monash Medical Centre and participated in this study under informed consent. Patients were excluded from the study if their original diagnosis of ESKD was type I or II diabetes, were on antibiotics, or had a recent infection or inflammatory flare-up. Parameters such as patient age, time of dialysis, erythropoietin (EPO) and statin use, and smoking status were collected, as these are known to influence the percentage of circulating EPCs, in addition to height, weight, and blood pressure. All human studies were approved by the Monash Health Human Research Ethics Committee (CF16/402-2016000182). A 10-ml quantity of blood was collected prior to a single hemodialysis session, and the peripheral blood mononuclear cell (PBMC) fraction was isolated, 11 seeded onto fibronectin (2 mg/cm 2 )Àcoated, 6-well plates and cultured in Endothelial Growth Media (EGM)À2 Microvascular Bullet Kit medium (Lonza, Mount Waverly, Australia) containing 5% fetal bovine serum, 0.04% hydrocortisone, 0.4% human fibroblast growth factor, and 0.1% of vascular endothelial growth factor (VEGF), R 3 Àinsulin-like growth factorÀ1, human epidermal growth factor, gentamicin, and amophotericin-B (catalog no. CC-3202, Lonza). Medium was changed after 72 hours and every second day thereafter. At 7 days after PBMC seeding, a CFU assay was performed. Cell culture continued for a total of 21 days or until OECs appeared, as identified by their extensive proliferation and cobblestone morphology. A small volume of whole blood (100 ml) was analyzed by flow cytometry for markers of EPCs, as identified by a subpopulation of CD31
RESULTS

Clinical Data
The patient cohort had a mean age of 64.2 (AE 15.5) years; 80% were male and 20% female. The mean blood pressure of patients prior to dialysis was 139.1 (AE 27.1)/75.2 (AE 18.9), and the mean time on hemodialysis was 46 months (AE 69.5). Half of the patients received EPO, 30% were administered statins, 15% were taking other medication including anticoagulants or blood thinners, and 65% had a history of smoking or were current smokers (Table 1) .
Circulating EPC Number Negatively Correlates
With Systolic Blood Pressure and Does Not Affect CFU or OEC Transformation The percentage of EPCs was identified using flow cytometry. EPCs were classified according to positive expression of both CD31 and CD34, in addition to positive or negative expression of vascular endothelial growth factor receptor. EPCs also had dim expression of CD45 (Figure 1a) . 12 The percentage of circulating EPCs in patients with ESKD ranged from 0.15% to 3.8% (Figure 1b) . Because of the impact that circulating EPC percentage has on the health of hemodialysis patients, 13 we investigated whether any clinical parameters had an effect on patient EPC levels in our cohort. Although patient age 14 and time on dialysis 15 have previously correlated with a decreased circulating EPC percentage, we did not find that these parameters influenced circulating EPC percentage in this cohort (Figure 2a and b) . However, patients receiving EPO had a significantly lower percentage of circulating EPCs compared to patients who were not administered EPO (mean difference 1.487 AE 0.538, 95% confidence interval [CI] ¼ 0.3À2.7, P ¼ 0.0184; Figure 2c ), and systolic blood pressure negatively correlated with EPC percentage, whereby, as systolic pressure increased, the percentage of EPCs decreased (r ¼ À0.59, P ¼ 0.033; Figure 2d ). There were no correlations observed between the starting EPC percentage and the number of CFUs formed (P ¼ 0.27; Figure 2d) , nor was the circulating EPC percentage a factor in determining whether patient cells successfully formed OEC colonies (P ¼ 0.19; Figure 2e ).
The Best Predictor of OEC Appearance in Culture Is Blood Pressure We observed a 45% conversion of EPCs to OECs, which were identified according to their cobblestone morphology and high proliferation rate. OECs appeared ) cells subgated with CD34 þ cells. Of these, the CD45 dim population was subgated, and CD31 þ expression on the resulting cells was confirmed on a CD31 histogram. This flow-cytometric protocol was used and established by Yoder et al. 12 Analysis was conducted using FlowJo software, and isotypes were used to for compensation. (b) Percentage of circulating EPCs for all patients in whole blood. The range of EPCs is spread from 3.8% down to 0.15% of whole blood in these patients (n ¼ 13) with ESKD. Data are mean AE SD. APC, allophycocyanin fluorescent protein; FSC-A, forward scatter area; FSC-H, forward scatter height; PE, phycoerythrin fluorescent protein.
as early as 7 days and as late as 17 days in culture (Figure 3a) . The number of CFUs counted at 7 days did not affect the appearance of OECs (P ¼ 0.24; Figure 3b ), nor did patient age, time on dialysis, or any other clinical parameter collected except for blood pressure (Figure 3c ). Patient cells that transformed into OECs had significantly lower systolic (mean difference 24.95 mm Hg, 95% CI ¼ 1.7À48.1, P ¼ 0.0365) and diastolic (mean difference 18.9 mm Hg, 95% CI ¼ 3.2À34.6, P ¼ 0.0208) blood pressures compared to patient cells that did not (Figure 3c ).
DISCUSSION
The primary aim of this study was to investigate whether patient clinical parameters affected circulating EPC percentage and the ability of isolated PBMCs to differentiate into angiogenic OECs. Interestingly, we found that patients administered EPO Figure 2 . Circulating endothelial progenitor cell (EPC) percentage negatively correlates with erythropoietin (EPO) use. The percentage of circulating EPCs was compared against clinical parameters from patients participating in the study (n ¼ 13). (a) Age and (b) months on dialysis were not correlated with the percentage of circulating EPCs. There was a correlation observed between patients who did not receive EPO administration by which they had significantly higher circulating EPCs compared to patients who did not receive EPO (c, P < 0.05). The percentage of EPCs in the peripheral circulation was also investigated against (d) statin use, (e) smoking status, (f) colony-forming unit (CFU) formation, and (g) late outgrowth endothelial cell (EC) formation, with no significant differences found. Data are mean AE SD and were analyzed using the Student t-test. *P < 0.05. 16 compared to healthy controls, which was suggested to be related to exposure to uremic toxins. [17] [18] [19] In addition, it has been reported that patients with hypertension have reduced EPC numbers and limited vascular regenerative potential when isolated EPCs are challenged in vitro, 20 which has also been found in patients who are obese or diabetic. 21 However 25 Our findings further suggest that high blood pressure reduces EPC numbers, and therefore may contribute to negative vascular health outcomes in the hemodialysis population, although this needs to be tested further in the clinical setting.
OECs are being investigated as a source for cell therapy with limited success due to senescence of cells in culture. 26 Here, we observed a 45% conversion rate of EPCs to OECs after an average of 12 days of PBMC culture. The success of conversion is thought to be associated with the starting volume of blood, and because EPCs are rare in the circulation, it has been suggested that large volumes of blood are required to obtain proliferative OEC colonies. 27 Unlike previous studies, 28 in our study we did not observe a correlation between starting EPC numbers and CFU after 7 days of culture. However, we showed that OEC colony transformation did occur if the blood pressure of the patient was lower before dialysis. A controlled blood pressure is linked with reduced cardiovascular events and a decrease in all-cause mortality in patients with stages 1 to 5 CKD, 29 and evidence suggests that controlling blood pressure, and therefore pulse pressure, in the dialysis population has similar outcomes. 30 There are limited data available about the characteristics of OECs isolated from patients with ESKD who are dialysis dependent and the clinical factors influencing their appearance in culture. The functional characteristics of OECs isolated from ESKD patients have been previously described, 31 including demonstration that OECs proliferate and form tubes in vitro, as well as contribute to in vivo neovascularization. Interestingly, this previous study demonstrated that increased age and high blood pressure contributed to the formation of mesenchymal stem cell colonies after isolation of the PBMC fraction from ESKD patients, yet had no effect on the appearance on OEC formation. 31 This, in combination with our findings, suggest that blood pressure may play a role in the formation of specific cell types in culture, which may influence the future use of autologous cell therapy. To further elucidate the full effect of blood pressure on circulating EPC percentage and OEC transformation in vitro, future studies with larger patient numbers are required. In our study, we were unable to determine whether there were any sex, age, and ethnicity differences that may be affecting both EPCs and OECs, due to the number of patients recruited to this study. Additionally, the patients recruited to this study were all using the same mode of dialysis, hemodialysis, and since there has been some suggestion that nocturnal dialysis normalizes blood pressure, increases the baroreflex sensitivity, and reduces cardiovascular mortality, 32 it would be interesting to investigate and compare the appearance of OECs isolated from patients undertaking different dialysis modalities.
In conclusion, our study suggests that a reduced blood pressure is beneficial for the vascular health of hemodialysis patients, increasing the number of circulating endothelial progenitor cells and the appearance of angiogenic OEC colonies in culture. . Blood pressure was significantly lower in patients whose cells went on to form OECs (systolic blood pressure, P < 0.0365; diastolic blood pressure, P < 0.0208). Data are mean AE SD and were analyzed using the Student t-test. Bar ¼ a: 500 mm; b: 50 mm. **P < 0.01, *P < 0.05. To the Editor: An important methodological issue concerning acute kidney injury (AKI) definitions 1 is the choice of "baseline" serum creatinine (SCr). [2] [3] [4] The most recent consensus definition proposes a rolling 48-hour window for AKI ascertainment during hospitalization, or the use of a baseline value that is "known or presumed to have occurred in the past 7 days." 1 However, significant misclassification in assigning AKI status can occur when admission or nadir inpatient SCr (as has been done in a number of studies) is used rather than a preadmission outpatient baseline. 4 A wellrecognized concern with the use of admission SCr to define baseline kidney function is that it will be higher than a patient's true baseline if communityacquired AKI is present, and therefore communityacquired AKI will be missed if the admission SCr is used to define baseline. However, animal and human studies have recently shown that creatinine generation can also quickly fall with acute illness, so falsely low readings may result. 5, 6 It is unknown whether changes in creatinine generation affect AKI ascertainment. Therefore, to quantitate variation in first inpatient SCr level and the impact on AKI ascertainment ( Figure  1a) , we compared preadmission baseline and first inpatient SCr in a large, population-based, hospitalized cohort. We also identified predictors of lower first inpatient SCr.
We identified all hospitalized adults without endstage renal disease at 21 Kaiser Permanente Northern California hospitals between 2006 and 2011 (Supplementary Figure S1) ; only the first eligible hospitalization per subject was included. Kaiser Permanente Northern California is a large integrated health care delivery system caring for > 4.1 million persons in the San Francisco Bay Area that is highly representative of the statewide population. 7 The study was approved by the institutional review boards of the Kaiser Foundation Research Institute and the University of California, San Francisco.
Baseline SCr was the most recent outpatient SCr from a maximum of 365 days and a minimum of 7 days preadmission. 8 We selected this as the gold standard because this definition has been used in prior studies examining the impact of baseline SCr on AKI ascertainment, including the prospective Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) study. 4, 8 A peak inpatient SCr $ 50% relative, $ 0.3 mg/dl absolute increase from the outpatient baseline, or need for acute dialysis defined AKI for this analysis. 1 Covariates included demographics, comorbidities, severity of illness, 9 preadmission estimated glomerular filtration rate (eGFR), and proteinuria. Comorbidities (diabetes, hypertension, cancer, coronary disease, chronic heart failure, prior ischemic stroke) were ascertained for up to 5 years before hospitalization using previously validated methods based on inpatient and ambulatory diagnoses and procedures, laboratory results, and pharmacy databases (codes available upon request). 10, 11 We identified coronary revascularization, sepsis, and acute heart failure occurring during the index hospitalization using relevant diagnosis and procedure codes. To further describe acute severity of illness, we determined whether patients were admitted to the intensive care unit during their stay and calculated the Laboratory-based Acute Physiology Score (LAPS) and COmorbidity Point Score (COPS), along with a validated predicted mortality score based on automated inpatient, outpatient and laboratory data. 
